Literature DB >> 1356563

Investigations of the subtype of alpha 2-adrenoceptor mediating contractions of the human saphenous vein.

K Smith1, S Connaughton, J R Docherty.   

Abstract

1. We have examined the effects of a series of alpha 2-adrenoceptor antagonists against isometric contractions to noradrenaline in human saphenous vein, and correlated these potencies with affinities for the alpha 2A-ligand binding site of human platelet and the alpha 2B-ligand binding site of rat kidney. 2. The alpha 2B-selective adrenoceptor antagonists, prazosin, ARC 239 and HV 723 showed high, and the alpha 2A-selective antagonist BRL 44408 showed low, potency in human saphenous vein. 3. Potency in human saphenous vein correlated better with affinity for the alpha 2B-ligand binding site (r = 0.71, n = 12, P less than 0.01) than with affinity for the alpha 2A-ligand binding site (r = 0.56, n = 12, non significant). 4. It is concluded that the postjunctional alpha 2-adrenoceptor of human saphenous vein resembles an alpha 2B-ligand binding site more than an alpha 2A-ligand binding site.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356563      PMCID: PMC1907513          DOI: 10.1111/j.1476-5381.1992.tb14354.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Delineation of three pharmacological subtypes of alpha 2-adrenoceptor in the rat kidney.

Authors:  S Uhlén; J E Wikberg
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

2.  Evidence that two stereochemically different alpha-2 adrenoceptors modulate norepinephrine release in rat cerebral cortex.

Authors:  L G Harsing; E S Vizi
Journal:  J Pharmacol Exp Ther       Date:  1991-01       Impact factor: 4.030

3.  Alpha-adrenoceptor subtypes in dog saphenous vein that mediate contraction and inositol phosphate production.

Authors:  P E Hicks; M Barras; G Herman; P Mauduit; J M Armstrong; B Rossignol
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

4.  Subclassification of the presynaptic alpha 2-autoreceptors in rabbit brain cortex.

Authors:  N Limberger; L Späth; K Starke
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

5.  Cloning and expression of a rat brain alpha 2B-adrenergic receptor.

Authors:  C S Flordellis; D E Handy; M R Bresnahan; V I Zannis; H Gavras
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

6.  Actions of 8-hydroxy-2-(N-dipropylamino) tetralin (8-OH-DPAT) at alpha 2-adrenoceptors.

Authors:  M Borton; S Connaughton; J R Docherty
Journal:  J Auton Pharmacol       Date:  1991-08

7.  Identification and characterization of alpha 2D-adrenergic receptors in bovine pineal gland.

Authors:  V Simonneaux; M Ebadi; D B Bylund
Journal:  Mol Pharmacol       Date:  1991-08       Impact factor: 4.436

8.  Pharmacological characterization of alpha-2 adrenergic receptor subtype involved in the release of insulin from isolated rat pancreatic islets.

Authors:  R Niddam; I Angel; S Bidet; S Z Langer
Journal:  J Pharmacol Exp Ther       Date:  1990-09       Impact factor: 4.030

9.  No evidence for differences between pre- and postjunctional alpha 2-adrenoceptors in the periphery.

Authors:  S Connaughton; J R Docherty
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

10.  Pharmacological subclassification of alpha 1-adrenoceptors in vascular smooth muscle.

Authors:  I Muramatsu; T Ohmura; S Kigoshi; S Hashimoto; M Oshita
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.